485 related articles for article (PubMed ID: 30808750)
21. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
[TBL] [Abstract][Full Text] [Related]
22. Telomere elongation through hTERT immortalization leads to chromosome repositioning in control cells and genomic instability in Hutchinson-Gilford progeria syndrome fibroblasts, expressing a novel SUN1 isoform.
Bikkul MU; Faragher RGA; Worthington G; Meinke P; Kerr ARW; Sammy A; Riyahi K; Horton D; Schirmer EC; Hubank M; Kill IR; Anderson RM; Slijepcevic P; Makarov E; Bridger JM
Genes Chromosomes Cancer; 2019 Jun; 58(6):341-356. PubMed ID: 30474255
[TBL] [Abstract][Full Text] [Related]
23. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides.
Fong LG; Vickers TA; Farber EA; Choi C; Yun UJ; Hu Y; Yang SH; Coffinier C; Lee R; Yin L; Davies BS; Andres DA; Spielmann HP; Bennett CF; Young SG
Hum Mol Genet; 2009 Jul; 18(13):2462-71. PubMed ID: 19376814
[TBL] [Abstract][Full Text] [Related]
24. Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement.
Folker ES; Ostlund C; Luxton GW; Worman HJ; Gundersen GG
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):131-6. PubMed ID: 21173262
[TBL] [Abstract][Full Text] [Related]
25. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.
Yang SH; Andres DA; Spielmann HP; Young SG; Fong LG
J Clin Invest; 2008 Oct; 118(10):3291-300. PubMed ID: 18769635
[TBL] [Abstract][Full Text] [Related]
26. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin.
Wang Y; Panteleyev AA; Owens DM; Djabali K; Stewart CL; Worman HJ
Hum Mol Genet; 2008 Aug; 17(15):2357-69. PubMed ID: 18442998
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
28. Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele.
Yang SH; Qiao X; Farber E; Chang SY; Fong LG; Young SG
J Biol Chem; 2008 Mar; 283(11):7094-9. PubMed ID: 18178963
[TBL] [Abstract][Full Text] [Related]
29. Muscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organization.
Meinke P; Mattioli E; Haque F; Antoku S; Columbaro M; Straatman KR; Worman HJ; Gundersen GG; Lattanzi G; Wehnert M; Shackleton S
PLoS Genet; 2014 Sep; 10(9):e1004605. PubMed ID: 25210889
[TBL] [Abstract][Full Text] [Related]
30. Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.
Kandert S; Lüke Y; Kleinhenz T; Neumann S; Lu W; Jaeger VM; Munck M; Wehnert M; Müller CR; Zhou Z; Noegel AA; Dabauvalle MC; Karakesisoglou I
Hum Mol Genet; 2007 Dec; 16(23):2944-59. PubMed ID: 17881656
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
32. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
[TBL] [Abstract][Full Text] [Related]
33. Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins.
Ostlund C; Folker ES; Choi JC; Gomes ER; Gundersen GG; Worman HJ
J Cell Sci; 2009 Nov; 122(Pt 22):4099-108. PubMed ID: 19843581
[TBL] [Abstract][Full Text] [Related]
34. ESCRT-III controls nuclear envelope deformation induced by progerin.
Arii J; Maeda F; Maruzuru Y; Koyanagi N; Kato A; Mori Y; Kawaguchi Y
Sci Rep; 2020 Nov; 10(1):18877. PubMed ID: 33139753
[TBL] [Abstract][Full Text] [Related]
35. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
Gabriel D; Roedl D; Gordon LB; Djabali K
Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
[TBL] [Abstract][Full Text] [Related]
36. A conserved splicing mechanism of the LMNA gene controls premature aging.
Lopez-Mejia IC; Vautrot V; De Toledo M; Behm-Ansmant I; Bourgeois CF; Navarro CL; Osorio FG; Freije JM; Stévenin J; De Sandre-Giovannoli A; Lopez-Otin C; Lévy N; Branlant C; Tazi J
Hum Mol Genet; 2011 Dec; 20(23):4540-55. PubMed ID: 21875900
[TBL] [Abstract][Full Text] [Related]
37. Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.
Kudlow BA; Stanfel MN; Burtner CR; Johnston ED; Kennedy BK
Mol Biol Cell; 2008 Dec; 19(12):5238-48. PubMed ID: 18843043
[TBL] [Abstract][Full Text] [Related]
38. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
[TBL] [Abstract][Full Text] [Related]
39. Reversal of laminopathies: the curious case of SUN1.
Chi YH; Chen CY; Jeang KT
Nucleus; 2012; 3(5):418-21. PubMed ID: 22895095
[TBL] [Abstract][Full Text] [Related]
40. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
Chen X; Yao H; Andrés V; Bergo MO; Kashif M
Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
